American Journal of Neuroradiology 25:261-269, February 2004
© 2004 American Society of Neuroradiology
BRAIN
Pretransplantation Conditioning Influence on the Occurrence of Cyclosporine or FK-506 Neurotoxicity in Allogeneic Bone Marrow Transplantation
a Department of Radiology, The Western Pennsylvania Hospital, Pittsburgh
b Department of Medicine, The Western Pennsylvania Hospital, Pittsburgh
Address reprint requests to Walter S. Bartynski, M.D., Department of Radiology, Division of Neuroradiology, University of Pittsburgh Medical Center, 200 Lothrop St., D132, Pittsburgh, PA 15213
BACKGROUND AND PURPOSE: Transplantation conditioning regimens have been shown to affect the brain imaging appearance in patients with cyclosporine or FK-506 neurotoxicity. We assessed whether the occurrence of neurotoxicity was affected by the choice of conditioning regimen used before allogeneic bone marrow transplantation (allo-BMT).
METHODS: An allo-BMT was performed in 290 patients conditioned before transplantation with myeloablative therapy. Neurotoxicity from cyclosporine or FK-506 developed in 21 (7.2%) of these patients, as confirmed with CT or MR imaging. Two hundred seventy-four (94%) of these 290 patients were conditioned with minor variations of one of five fundamental regimens: cyclophosphamide (Cy)/busulfan (n = 97), Cy/total body irradiation (TBI) (n = 122), Cy/thiotepa/TBI (n = 40), bischloroethylnitrosourea/etoposide/cytarabine/melphalan, or BEAM (n = 10), and Cy/thiotepa/busulfan (n = 5). The remaining 16 patients were prepared with variable regimens. The rates of occurrence of cyclosporine or FK-506 neurotoxicity relative to these conditioning regimens were compared.
RESULTS: The lowest rate of cyclosporine or FK-506 neurotoxicity was found in those patients conditioned with Cy (2 days)/busulfan (4 days) (5.1%) or Cy (2 days)/TBI (4 days) (5.9%). Rate of neurotoxicity increased with lengthier conditioning regimens. A high rate of neurotoxicity was present in those patients conditioned with Cy (4 days)/TBI (4 days) (13.7%), and this was statistically significant (P < .05) when compared with Cy (2 days)/busulfan (4 days).
CONCLUSION: The rate of occurrence of cyclosporine or FK-506 neurotoxicity varies with the conditioning regimen used, with lengthier regimens associated with a higher rate of neurotoxicity. As the length of the conditioning regimen equates to the total dose of chemotherapy administered, it suggests that the intensity of the regimen is correlated to the predisposition to neurotoxicity from cyclosporine or FK-506.
This article has been cited by other articles:
 |
|
 |
|
  H.M. Hefzy, W.S. Bartynski, J.F. Boardman, and D. Lacomis Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features AJNR Am. J. Neuroradiol., August 1, 2009; 30(7): 1371 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishiguchi, K. Mochizuki, M. Shakudo, T. Takeshita, M. Hino, and Y. Inoue CNS Complications of Hematopoietic Stem Cell Transplantation Am. J. Roentgenol., April 1, 2009; 192(4): 1003 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1043 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski, H.P. Tan, J.F. Boardman, R. Shapiro, and J.W. Marsh Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski, J.F. Boardman, Z.R. Zeigler, R.K. Shadduck, and J. Lister Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2179 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Besenski, Z. Rumboldt, O. Emovon, J. Nicholas, S. Kini, J. Milutinovic, and M. N. Budisavljevic Brain MR Imaging Abnormalities in Kidney Transplant Recipients AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2282 - 2289. [Abstract] [Full Text] [PDF]
|
|